Literature DB >> 11445060

Syncope.

Pamela Nerheim1, Brian Olshansky.   

Abstract

Successful treatment of patients with syncope depends on the accuracy of the diagnosis, because syncope is a symptom, not a disease; diagnosis of the cause for syncope therefore creates a blueprint for treatment. Most experienced practitioners can diagnose the cause of syncope for less than half of their patients. Excessive and repeat testing is expensive and may not improve the chance of a correct diagnosis. Patient history is the key to the diagnosis. Treatment may vary from a lifestyle change to open heart surgery. The great challenge of treating patients with syncope is to provide cost-effective, safe therapy to those with a benign course and still provide needed treatment for those whose syncope is life threatening.

Entities:  

Year:  2001        PMID: 11445060     DOI: 10.1007/s11936-001-0092-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  46 in total

Review 1.  Tilt table testing for assessing syncope. American College of Cardiology.

Authors:  D G Benditt; D W Ferguson; B P Grubb; W N Kapoor; J Kugler; B B Lerman; J D Maloney; A Raviele; B Ross; R Sutton; M J Wolk; D L Wood
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

Review 2.  Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians.

Authors:  M Linzer; E H Yang; N A Estes; P Wang; V R Vorperian; W N Kapoor
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

3.  Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial.

Authors:  P Alboni; C Menozzi; M Brignole; N Paparella; G Gaggioli; G Lolli; R Cappato
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

Review 4.  A review of pathophysiology and therapy of patients with vasovagal syncope.

Authors:  C M White; J P Tsikouris
Journal:  Pharmacotherapy       Date:  2000-02       Impact factor: 4.705

5.  Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia.

Authors:  G Jacob; J R Shannon; B Black; I Biaggioni; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

6.  Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.

Authors:  M M Cox; B A Perlman; M R Mayor; T A Silberstein; E Levin; L Pringle; A Castellanos; R J Myerburg
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

7.  Efficacy of different treatment strategies for neurocardiogenic syncope.

Authors:  A Natale; J Sra; A Dhala; A Wase; M Jazayeri; S Deshpande; Z Blanck; M Akhtar
Journal:  Pacing Clin Electrophysiol       Date:  1995-04       Impact factor: 1.976

8.  DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope.

Authors:  F Ammirati; F Colivicchi; S Toscano; C Pandozi; M T Laudadio; F De Seta; M Santini
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

9.  Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.

Authors:  H Calkins; M Seifert; F Morady
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

10.  Usefulness of pindolol in neurocardiogenic syncope.

Authors:  D Iskos; J Dutton; M M Scheinman; K G Lurie
Journal:  Am J Cardiol       Date:  1998-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.